|
|
 |
 |
 |
BPH Explained
March 4, 1999 - Boca Raton, FL. For many men, benign prostatic hyperplasia (BPH) is a fact of life as we grow older. BPH is the enlargement of the prostate gland due to the natural aging process rather than illness.
It's called benign prostatic hyperplasia because it's rarely life threatening. Urinary urgency, frequency, leaking, and a diminished urinary flow are among the annoying symptoms. However, BPH left untreated can seriously affect a man's quality of life. Infection, incontinence, bladder stones, kidney damage and renal failure can be unwelcome consequences of ignoring the condition.
One major obstacle to early treatment is patient reticence. In spite of obvious symptoms and the fact that BPH is as much a part of aging as graying hair, many men have difficulty discussing urinary and sexual issues with their doctors.
But there's good news for those wise enough to consult their physicians, because treatment is getting better all the time. Medications including hormonal therapy and alpha-blockers such as Hytrin, which is also indicated for hypertension, are available now to help alleviate the symptoms of BPH. And much to the delight of patients and doctors alike, today's surgical treatments are far less invasive than those of the past. These newer techniques include laser, TUNA, and microwave therapies.
The Cutting Edge Medical Report will feature BPH Explained: What Every Man Should Know in a 30-minute TV program co-hosted by Herbert Lepor, M.D., Professor and Chairman of the Department of Urology at the New York University School of Medicine, and Mitchell Steiner, M.D., Director of Urological Oncology and Research at the University of Tennessee at Memphis.
This program is produced by Information Television and is made possible by Abbott Laboratories.
This program is scheduled to air on Thursday, March 11, at 7:00 a.m. Eastern and Pacific times, 6:00 a.m. Central time, and 8:00 a.m. Mountain time. For additional information on air dates, times and stations, please call 1-888-380-6500.
 |
 |
|